Atezolizumab monoclonal antibody drug. Targets programmed cell death-ligand 1 (PD-L1, immune checkpoint inhibitor) and is used in the treatment of can

---

Atezolizumab monoclonal antibody drug. Targets programmed cell death-ligand 1 (PD-L1, immune checkpoint inhibitor) and is used in the treatment of cancer. Generic name and stylized antibody.

---

Size: 9000px × 3214px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: antibody, atezolizumab, biological, biosimilar, biotech, biotechnology, blocker, cancer, cell, checkpoint, death, disease, drug, immune, immuno-oncology, immunoglobulin, immunology, immunotherapy, infusion, inhibition, inhibitor, injection, inn, ligand, mab, monoclonal, nomenclature, oncology, pd-l1, pdl1, peptide, programmed, protein, tumor